Home
Conditions
Turcot syndrome

Clinical trial condition

Turcot syndrome

Explore clinical trials studying Turcot syndrome. Study availability and eligibility vary by location and protocol.

49 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Turcot syndrome trial results

Active, not recruiting

Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin

NCT05118724

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: Westdeutsches Tumorzentrum Essen, Germany

View Trial Details

Active, not recruiting

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

NCT02983578

Conditions: Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, +46 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Liquid Biopsy Biomarkers for Endoscopic Surveillance in Lynch Syndrome

NCT07838246

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +24 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions: Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations: The Sarah Cannon Research Institute Nashville, Tennessee, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

Leuven Cancer Institute Leuven, Belgium

Princess Margaret Cancer Center Toronto, Ontario, Canada

View Trial Details

Completed

Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome

NCT05257057

Conditions: Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +33 more
Locations: WellSpan York, Pennsylvania, United States

View Trial Details

Completed

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

NCT03053466

Conditions: Cancer of Unknown Primary Site, Genomic Instability, Microsatellite Instability, +9 more
Locations: Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

Cabrini Health Limited Malvern, Victoria, Australia

Peter MaCallum Cancer Centre Melbourne, Victoria, Australia

Nucleus Network Melbourne, Victoria, Australia

View Trial Details

Completed

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

NCT03652077

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +96 more
Locations: The Angeles Clinical and Research Institute Los Angeles, California, United States

University of Mississippi Jackson, Mississippi, United States

Hackensack Medical Center Hackensack, New Jersey, United States

Carolina BioOncology Huntsville, North Carolina, United States

View Trial Details

Completed

Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)

NCT04439214

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +23 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival

NCT04482608

Conditions: Colorectal Cancer Metastatic, Microsatellite Instability High, Mismatch Repair Deficiency, +1 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Turcot syndrome

Turcot syndrome trial results

Related conditions